Low-dose rt-PA may not decrease the incidence of symptomatic intracranial haemorrhage in patients with high risk of symptomatic intracranial haemorrhage-Reference-Cited by-同舟云学术

Low-dose rt-PA may not decrease the incidence of symptomatic intracranial haemorrhage in patients with high risk of symptomatic intracranial haemorrhage

Published:2019-03-01 Issue:5 Volume:41 Page:473-479
ISSN:0161-6412
Container-title:Neurological Research
language:en
Short-container-title:Neurological Research

Author:

Liu Mingyong¹,Pan Yuesong²³,Zhou Lichun¹,Wang Yongjun⁴⁵⁶⁷

Affiliation:

1. Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

2. Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China

3. Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China

4. Center of Stroke, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

5. National Clinical Research Center for Neurological Diseases, Beijing, China

6. Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China

7. Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China

Funder

National Science and Technology Major Project of China

State Key Development Program of Basic Research of China

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/01616412.2019.1580454

Reference46 articles.

1. Tissue Plasminogen Activator for Acute Ischemic Stroke

2. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

3. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis

4. Intravenous Thrombolysis in Thai Patients with Acute Ischemic Stroke: Role of Aging

5. Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Effectiveness and Safety of Low-Dose Versus Standard-Dose Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke: A Meta-Analysis;Cureus;2023-02-28

2. Low-dose vs. standard-dose alteplase for Chinese patients with acute ischemic stroke: A propensity score analysis;Frontiers in Neurology;2023-02-21

3. Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis;Frontiers in Neurology;2022-06-23

4. Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence;Therapeutic Advances in Neurological Disorders;2021-01